BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34677831)

  • 1. d-Galactose treatment increases ACE2, TMPRSS2, and FURIN and reduces SERPINA1 mRNA expression in A549 human lung epithelial cells.
    Baristaite G; Gurwitz D
    Drug Dev Res; 2022 May; 83(3):622-627. PubMed ID: 34677831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol reduces ACE2 and TMPRSS2 mRNA levels in A549 human lung epithelial cells.
    Baristaite G; Gurwitz D
    Drug Dev Res; 2022 Jun; 83(4):961-966. PubMed ID: 35103351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In well-differentiated primary human bronchial epithelial cells, TGF-
    O'Sullivan MJ; Mitchel JA; Mwase C; McGill M; Kanki P; Park JA
    Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L246-L253. PubMed ID: 33174447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication.
    Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
    Fließer E; Birnhuber A; Marsh LM; Gschwandtner E; Klepetko W; Olschewski H; Kwapiszewska G
    J Pathol Clin Res; 2021 Sep; 7(5):446-458. PubMed ID: 33978304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous expression of ACE2, TMPRSS2, and FURIN at single-cell resolution in advanced non-small cell lung cancer.
    Liu Z; Gu X; Li Z; Shan S; Wu F; Ren T
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3563-3573. PubMed ID: 35960376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease.
    Khoury EE; Knaney Y; Fokra A; Kinaneh S; Azzam Z; Heyman SN; Abassi Z
    J Cell Mol Med; 2021 Apr; 25(8):3840-3855. PubMed ID: 33660945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
    Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile of SARS-CoV-2 cellular entry proteins in normal oral mucosa and oral squamous cell carcinoma.
    Sapkota D; Sharma S; Søland TM; Braz-Silva PH; Teh MT
    Clin Exp Dent Res; 2022 Feb; 8(1):117-122. PubMed ID: 34726347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Investigation of SARS-CoV-2 Receptor Protein Distribution along Viral Entry Routes in Humans.
    Bräutigam K; Reinhard S; Galván JA; Wartenberg M; Hewer E; Schürch CM
    Respiration; 2022; 101(6):610-618. PubMed ID: 35038715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19.
    Bai X; Hippensteel J; Leavitt A; Maloney JP; Beckham D; Garcia C; Li Q; Freed BM; Ordway D; Sandhaus RA; Chan ED
    Med Hypotheses; 2021 Jan; 146():110394. PubMed ID: 33239231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.
    Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z
    Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ACE2, TMPRSS2, and Furin in Mouse Ear Tissue, and the Implications for SARS-CoV-2 Infection.
    Uranaka T; Kashio A; Ueha R; Sato T; Bing H; Ying G; Kinoshita M; Kondo K; Yamasoba T
    Laryngoscope; 2021 Jun; 131(6):E2013-E2017. PubMed ID: 33296096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
    Torre-Fuentes L; Matías-Guiu J; Hernández-Lorenzo L; Montero-Escribano P; Pytel V; Porta-Etessam J; Gómez-Pinedo U; Matías-Guiu JA
    J Med Virol; 2021 Feb; 93(2):863-869. PubMed ID: 32691890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
    Gkogkou E; Barnasas G; Vougas K; Trougakos IP
    Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2.
    Tarek M; Abdelzaher H; Kobeissy F; El-Fawal HAN; Salama MM; Abdelnaser A
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity.
    Sakaguchi W; Kubota N; Shimizu T; Saruta J; Fuchida S; Kawata A; Yamamoto Y; Sugimoto M; Yakeishi M; Tsukinoki K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.